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Abstract: 
 
Circulatory and vascular control differs between wakefulness and sleep. Few studies have used physiological 
recordings during sleep for assessment of cardiovascular (CV) function and risk. This thesis addresses the 
physiological link between nocturnal peripheral vascular tone, measured by a novel finger photoplethysmographic 
signal – PAT (peripheral arterial tone), and obstructive sleep apnea (OSA). The validity of using such a signal for 
OSA diagnostics and CV risk classification is also studied.  
 
The amplitude of the PAT signal was periodically attenuated, reflecting vasoconstriction, during the immediate post 
apnea/hypopnea period. These attenuations were largely reversed by cumulative dosages of phentolamine (α-receptor 
antagonist) infusion via the brachial artery during sleep in eight patients with severe OSA. This effect suggests that 
OSA-related PAT attenuation is mediated via a sympathoadrenergic α-receptor mechanism.   
 
Adrenergic α-receptor mechanisms were further evaluated in a double-blind crossover study comparing equipotent 
dosages of doxazosin (a peripheral α-receptor inhibitor) and enalapril (an angiotensin-converting enzyme inhibitor) 
on digital vasoconstriction and nocturnal blood pressure (BP). While the nighttime beat-to-beat finger BP was 
significantly higher under doxazosin treatment, the apnea related PAT attenuation decreased during doxazosin 
compared with enalapril treatment (P<0.001) in 16 hypertensive OSA patients. An analysis of sleep related changes 
of PAT demonstrated that attenuations were influenced by apnea related oxygen desaturation and rapid eye 
movement sleep.  
 
A portable monitoring device, Watch_PAT100 (WP100), was validated against unattended polysomnography (PSG) 
for OSA diagnosis in 98 subjects recruited from the Skaraborg Hypertension and Diabetes Project. The WP100 
records PAT, pulse rate, oxygen saturation and actigraphy for automatic analysis of the sleep-wake state, respiratory 
disturbance index (RDI), apnea-hypopnea index (AHI) and oxygen desaturation index (ODI). The WP100 RDI, AHI, 
and ODI correlated closely with the corresponding indices obtained by PSG. The area under the ROC curves for 
WP100 AHI and RDI were 0.93 and 0.90 when the AHI and RDI thresholds 10 and 20 were applied respectively. A 
new standard for limited-channel device validation using simultaneous PSG recording in the home environment was 
proposed. 
 
The relationship between nocturnal PAT attenuation and office BP was investigated in 81 subjects from the same 
study population. Episodic attenuations of the PAT signal were identified and characterized. In a generalized least 
squares regression model, we found an association between median PAT attenuation (PWA.att) and office BP which 
was independent of gender, age, body mass index, antihypertensive medication, number of attenuation episodes, AHI, 
ODI and arousal index. Each 10% increase in PWA.att was associated with an increase of 5.0 mmHg systolic BP and 
3.0 mmHg diastolic BP, respectively. Continuous assessment of PAT during sleep appears to reflect vascular 
regulation and homeostasis. 
 
An autonomic state indicator algorithm based on a novel finger pulse oximetry sensor was developed and validated 
for CV risk assessment according to the ESH/ESC risk factor matrix. Five signal components reflecting cardiac and 
vascular activity (pulse wave attenuation, pulse rate acceleration, pulse propagation time, respiration related pulse 
oscillation and oxygen desaturation) were extracted in 99 subjects and used to construct an algorithm. The capacity of 
the algorithm for CV risk prediction was validated in 49 additional subjects. The sensitivity and specificity of the 
algorithm to distinguish high/low CV risk in the validation group was 80% and 77%, respectively. The area under the 
ROC curve for high CV risk classification was 0.84. Based on this data, we propose that information derived from a 
photoplethysmographic signal obtained during sleep may be applied as a useful tool for CV risk classification. 
 
This thesis supports the notion that PAT, as a measure of finger pulsatile volume changes, reflects the sympathetic 
autonomic activity and can be used for the detection of sleep disordered breathing. Information derived from an 
oximeter based pulse wave signal may be used to assess CV function and CV risk.    
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